Adrecizumab in Cardiogenic Shock

Conditions:   Cardiogenic Shock;   Endothelial Dysfunction Interventions:   Biological: Adrecizumab;   Drug: Placebo Sponsor:   Dr. med. Mahir Karakas Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials